PL2393830T3 - Peptydy traw dla szczepionki - Google Patents

Peptydy traw dla szczepionki

Info

Publication number
PL2393830T3
PL2393830T3 PL10704399T PL10704399T PL2393830T3 PL 2393830 T3 PL2393830 T3 PL 2393830T3 PL 10704399 T PL10704399 T PL 10704399T PL 10704399 T PL10704399 T PL 10704399T PL 2393830 T3 PL2393830 T3 PL 2393830T3
Authority
PL
Poland
Prior art keywords
vaccine
grass
peptides
grass peptides
Prior art date
Application number
PL10704399T
Other languages
English (en)
Inventor
Rod Hafner
Paul Laidler
Guy Layton
Mark Larche
Original Assignee
Circassia Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0901927.4A external-priority patent/GB0901927D0/en
Priority claimed from GB0901928A external-priority patent/GB0901928D0/en
Priority claimed from GB0912578A external-priority patent/GB0912578D0/en
Priority claimed from PCT/GB2009/001995 external-priority patent/WO2010018384A1/en
Priority claimed from GB0917871A external-priority patent/GB0917871D0/en
Application filed by Circassia Ltd filed Critical Circassia Ltd
Publication of PL2393830T3 publication Critical patent/PL2393830T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56977—HLA or MHC typing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pulmonology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
PL10704399T 2009-02-05 2010-02-05 Peptydy traw dla szczepionki PL2393830T3 (pl)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GBGB0901927.4A GB0901927D0 (en) 2009-02-05 2009-02-05 Peptide for IL10 production
GB0901928A GB0901928D0 (en) 2009-02-05 2009-02-05 Peptides for vaccine
GB0912578A GB0912578D0 (en) 2009-07-20 2009-07-20 Peptide for IL-10 production
PCT/GB2009/001995 WO2010018384A1 (en) 2008-08-15 2009-08-14 T-cell antigen peptide from allergen for stimulation of il-10 production
GB0917871A GB0917871D0 (en) 2009-10-12 2009-10-12 Peptides for vaccine
PCT/GB2010/000198 WO2010089554A1 (en) 2009-02-05 2010-02-05 Peptides for vaccine
EP10704399.4A EP2393830B8 (en) 2009-02-05 2010-02-05 Grass peptides for vaccine

Publications (1)

Publication Number Publication Date
PL2393830T3 true PL2393830T3 (pl) 2015-07-31

Family

ID=42082585

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10704399T PL2393830T3 (pl) 2009-02-05 2010-02-05 Peptydy traw dla szczepionki

Country Status (23)

Country Link
US (2) US8753644B2 (pl)
EP (2) EP2891662A1 (pl)
JP (2) JP5746053B2 (pl)
KR (1) KR20110111307A (pl)
CN (2) CN103784952B (pl)
AU (1) AU2010212193B2 (pl)
BR (1) BRPI1008802A2 (pl)
CA (1) CA2751500A1 (pl)
DK (1) DK2393830T3 (pl)
EA (1) EA020792B1 (pl)
ES (1) ES2532759T3 (pl)
GB (1) GB2469894B (pl)
HK (1) HK1212358A1 (pl)
HR (1) HRP20150317T1 (pl)
IL (1) IL214257A (pl)
MX (1) MX2011008179A (pl)
NZ (1) NZ594268A (pl)
PL (1) PL2393830T3 (pl)
PT (1) PT2393830E (pl)
SG (1) SG173523A1 (pl)
SI (1) SI2393830T1 (pl)
WO (1) WO2010089554A1 (pl)
ZA (1) ZA201105436B (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2469894B (en) * 2009-02-05 2011-09-07 Circassia Ltd Peptides for use in treating allergy to grass pollen
AU2012249553A1 (en) * 2011-04-29 2013-10-24 Selecta Biociences, Inc. Tolerogenic synthetic nanocarriers for allergy therapy
MX2015015231A (es) 2013-05-03 2016-07-06 Selecta Biosciences Inc Métodos y composiciones para mejorar las células t reguladoras de cd4+.
IL292575A (en) 2014-09-07 2022-06-01 Selecta Biosciences Inc Methods and preparations for weakening immune responses by modulating gene expression in an antiviral transfer system
US11013781B2 (en) * 2015-07-01 2021-05-25 Alk-Abelló As Peptide combinations and uses thereof for treating grass allergy
AU2018236123B2 (en) 2017-03-11 2024-04-18 Selecta Biosciences, Inc. Methods and compositions related to combined treatment with anti-inflammatories and synthetic nanocarriers comprising an immunosuppressant
US11524019B2 (en) 2017-08-21 2022-12-13 Glycom A/S Synthetic composition for reducing allergy symptoms
CN108802216B (zh) * 2018-05-23 2021-04-16 山东出入境检验检疫局检验检疫技术中心 一种使用区域敏感性蛋白组和/或多肽组鉴别刺参产地的方法

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340729C (en) 1988-03-23 1999-09-07 Mohan Bir Singh Ryegrass pollen allergen
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5399346A (en) 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
DE69128039T2 (de) 1990-08-17 1998-03-05 Penelope Smith Allergene aus roggenspreupollen
WO1992016554A1 (en) 1991-03-14 1992-10-01 The University Of Melbourne Protein allergens of the species cynodon dactylon
WO1994001560A1 (en) 1991-07-12 1994-01-20 Immulogic Pharmaceutical Corporation Allergenic proteins and peptides from japanese cedar pollen
NZ270897A (en) 1991-08-16 1997-06-24 Univ Melbourne Treatment of sensitivity to ryegrass pollen
WO1993010236A1 (en) 1991-11-15 1993-05-27 The University Of Melbourne Protein allergens of the species cynodon dactylon
US6441157B1 (en) 1991-11-15 2002-08-27 University Of Melbourne Nucleic acid sequences encoding protein allergens of the species Cynodon dactylon
JP3868480B2 (ja) 1992-08-14 2007-01-17 ザ・ユニバーシテイ・オブ・メルボルン ライグラス花粉アレルゲンのｔ細胞エピトープ
US5480972A (en) 1992-10-30 1996-01-02 The University Of Melbourne Allergenic proteins from Johnson grass pollen
US6214358B1 (en) 1992-10-30 2001-04-10 Immulogic Pharamaceutical Corp. Protein allergens of the species Cynodon dactylon
WO1994021675A2 (en) 1993-03-12 1994-09-29 Immulogic Pharmaceutical Corporation T cell epitopes of ryegrass pollen allergen
NZ271818A (en) * 1993-08-13 1997-11-24 Immulogic Pharma Corp T cell epitopes of ryegrass pollen antigen
US5820862A (en) 1994-04-14 1998-10-13 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from dermatophagoides (house dust mite)
GB9412714D0 (en) 1994-06-24 1994-08-17 Lewin Ian V T cill epitopes
WO1996003106A2 (en) * 1994-07-26 1996-02-08 University Of Manitoba Allergenic peptides derived from poa pratensis
US7112333B1 (en) * 1994-08-05 2006-09-26 Heska Corporation T cell epitopes of ryegrass pollen allergen
IL115744A (en) 1994-10-27 2000-07-16 Akzo Nobel Nv Peptides comprising a subsequence of human cartilage glycoprotein - 39
AT402505B (de) 1995-08-02 1997-06-25 Biomay Prod & Handel Rekombinantes 60 kda pflanzliches panallergen (kofaktor-unabhängige phosphoglyceratmutase; e.c. 5.4.2.1.)
CA2317724A1 (en) 1998-01-09 1999-07-15 Circassia Limited Methods and compositions for desensitisation
DE19823097A1 (de) * 1998-05-22 1999-11-25 Max Planck Gesellschaft Mittel gegen saisonale Typ-I-Allergien und bakterielle Infektionen
US6989146B2 (en) 2000-08-09 2006-01-24 The Regents Of The University Of California Stress proteins and peptides and methods of use thereof
AUPR775401A0 (en) * 2001-09-18 2001-10-11 Monash University Novel Epitopes and Uses Thereof
ATE414534T1 (de) 2001-12-05 2008-12-15 Circassia Ltd Immunotherapeutische methoden und systeme
AUPS148202A0 (en) * 2002-04-02 2002-05-09 Monash University Immunotherapeutic and immunoprophylactic reagents
WO2003088997A2 (en) 2002-04-22 2003-10-30 Universiteit Utrecht Holding B.V. Reduction of unwanted immune reactions
GB0210741D0 (en) 2002-05-10 2002-06-19 Medical Res Council Methods of therapy
GB0308988D0 (en) 2003-04-17 2003-05-28 Univ Singapore Molecule
DE102004035337A1 (de) * 2004-07-21 2006-03-16 Merck Patent Gmbh Varianten der Gruppe 1-Allergene aus Poaceae mit reduzierter Allergenität und erhaltener T-Zellreaktivität
WO2006075253A2 (en) 2005-01-11 2006-07-20 Commissariat A L'energie Atomique Peptides for desensitizing subjects allergic to dog hair and dander and compositions containing said peptides.
WO2006132607A1 (en) 2005-06-10 2006-12-14 National University Of Singapore Mutant allergen(s)
DE202005009990U1 (de) * 2005-06-25 2006-11-02 Hengst Gmbh & Co.Kg Vorrichtung zum Abscheiden von Ölteilchen aus dem Kurbelgehäuseentlüftungsgas einer Brennkraftmaschine
US20070092532A1 (en) 2005-10-25 2007-04-26 Board Of Trustees Operating Michigan State University Arthritis vaccines and methods
PT2119450E (pt) 2005-11-29 2013-04-26 Actogenix Nv Indução de tolerância da mucosa a autoantigénios de células beta de ilhéus pancreáticos
AT503690A1 (de) * 2006-06-09 2007-12-15 Biomay Ag Hypoallergene moleküle
US20110038881A1 (en) 2007-05-09 2011-02-17 Circassia Limited Prognostic assay for determining t cell response to hla antigens and use thereof in field of tissue transplantation
GB0710529D0 (en) 2007-06-01 2007-07-11 Circassia Ltd Vaccine
CN103272227B (zh) 2007-08-15 2014-12-10 切尔卡西亚有限公司 针对过敏原去敏化的肽
EP2042193A1 (en) 2007-09-28 2009-04-01 Biomay AG RNA Vaccines
EP2331124A1 (en) 2008-08-15 2011-06-15 Circassia Limited T-cell antigen peptide from allergen for stimulation of il-10 production
GB2469894B (en) * 2009-02-05 2011-09-07 Circassia Ltd Peptides for use in treating allergy to grass pollen

Also Published As

Publication number Publication date
JP6215252B2 (ja) 2017-10-18
EP2393830A1 (en) 2011-12-14
BRPI1008802A2 (pt) 2016-03-08
KR20110111307A (ko) 2011-10-10
PT2393830E (pt) 2015-04-23
NZ594268A (en) 2013-05-31
JP5746053B2 (ja) 2015-07-08
CN102307893A (zh) 2012-01-04
ES2532759T3 (es) 2015-03-31
HK1212358A1 (en) 2016-06-10
US8753644B2 (en) 2014-06-17
GB2469894A (en) 2010-11-03
MX2011008179A (es) 2011-09-09
CN103784952A (zh) 2014-05-14
EP2393830B1 (en) 2015-01-28
EP2393830B8 (en) 2015-03-18
IL214257A (en) 2016-06-30
CA2751500A1 (en) 2010-08-12
HRP20150317T1 (hr) 2015-04-24
EA201171001A1 (ru) 2012-02-28
US20120148612A1 (en) 2012-06-14
CN102307893B (zh) 2014-03-26
AU2010212193A1 (en) 2011-08-18
WO2010089554A8 (en) 2011-10-06
SG173523A1 (en) 2011-09-29
WO2010089554A1 (en) 2010-08-12
AU2010212193B2 (en) 2015-05-14
EP2891662A1 (en) 2015-07-08
GB2469894B (en) 2011-09-07
GB201001954D0 (en) 2010-03-24
US20140302071A1 (en) 2014-10-09
DK2393830T3 (en) 2015-04-27
JP2012516693A (ja) 2012-07-26
EA020792B1 (ru) 2015-01-30
JP2015180646A (ja) 2015-10-15
CN103784952B (zh) 2016-08-17
SI2393830T1 (sl) 2015-04-30
IL214257A0 (en) 2011-09-27
ZA201105436B (en) 2012-09-26

Similar Documents

Publication Publication Date Title
IL217008A0 (en) Vaccine
GB0905570D0 (en) Combined vaccines
PL2496596T3 (pl) Peptydy terapeutyczne
GB201012651D0 (en) Peptides
GB201006165D0 (en) Vaccine
GB201001954D0 (en) Grass peptides for vaccine
GB201002559D0 (en) Birch peptides for vaccine
GB201014965D0 (en) Vaccine
GB0907935D0 (en) Vaccines
IL216102A0 (en) Combined measles-malaria vaccine
ZA201108446B (en) FViII-DERIVED PEPTIDES
GB201000522D0 (en) Vaccine
GB201013006D0 (en) Vaccine
GB201006324D0 (en) Vaccine
GB0918782D0 (en) A protein as an adjuvant for a vaccine
IL217194A0 (en) Vaccine
ZA201302154B (en) Vaccine
GB0901928D0 (en) Peptides for vaccine
GB0902344D0 (en) Peptides for vaccine
GB0917871D0 (en) Peptides for vaccine
GB0902345D0 (en) Peptides for vaccine
GB201001624D0 (en) Peptides for vaccine
GB201010058D0 (en) Peptide vaccine
GB201010056D0 (en) Polypeptide vaccine
GB0914545D0 (en) Vaccine